Articles publiés

Cancer incidence in Morocco: report from Casablanca registry 2005-2007.

http://www.ncbi.nlm.nih.gov/pubmed/24570792

Cancer incidence in Rabat, Morocco: 2006-2008

http://www.ncbi.nlm.nih.gov/pubmed/23940493

Epidemiological and pathological features of cancer in Fez Boulemane region, Morocco

http://www.ncbi.nlm.nih.gov/pubmed/23879078

The Practice of Medical Oncology in Morocco: The National Study of the Moroccan Group of Trialist in Medical Oncology (EVA-Onco).

http://www.ncbi.nlm.nih.gov/pubmed/24223311

Determinants of “lost to follow-up” status among patients treated for cancer in Morocco: situation before the Cancer Plan.

http://www.ncbi.nlm.nih.gov/pubmed/25400850

Lost to follow-up in radiotherapy: experience of the National Institute of Oncology in Morocco.

http://www.ncbi.nlm.nih.gov/pubmed/25584129

The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 BreastCancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients.

http://www.ncbi.nlm.nih.gov/pubmed/24447401

Efficacy and safety of bevacizumab in the treatment of human epidermal growth factor receptor type 2 negative metastatic breast cancer: About a large series in moroccan population.

http://www.ncbi.nlm.nih.gov/pubmed/25494121

Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008.

http://www.ncbi.nlm.nih.gov/pubmed/24387242

Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients.

http://www.ncbi.nlm.nih.gov/pubmed/23985308

The CHEK2 1100delC allelic variant is not present in familial and sporadic reast cancer cases from Moroccan population.

http://www.ncbi.nlm.nih.gov/pubmed/25674498

Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

http://www.ncbi.nlm.nih.gov/pubmed/25201062

Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma.

http://www.ncbi.nlm.nih.gov/pubmed/24729895

Frequency and type of epidermal growth factor receptor mutations in moroccan patients with lung adenocarcinoma.

http://www.ncbi.nlm.nih.gov/pubmed/23945389

Targeted therapy in thyroid cancer: Towards a treatment card.

http://www.ncbi.nlm.nih.gov/pubmed/25555494

Images in clinical medicine. Bilateral lower palpebral MALT lymphoma.

http://www.ncbi.nlm.nih.gov/pubmed/25607429

Vismodegib: the proof of concept in Basal cell carcinoma.

http://www.ncbi.nlm.nih.gov/pubmed/24932107

Clinical prognostic factors in locally advanced nasopharyngeal carcinoma in Moroccan population.

http://www.ncbi.nlm.nih.gov/pubmed/23996865